Evidence map›Paper›PMID 34031524›Full record

ArticleScientific reports2021

Remote ischemic preconditioning improves tissue oxygenation in a porcine model of controlled hemorrhage without fluid resuscitation.

Gal Yaniv, Arik Eisenkraft, Lilach Gavish, Linn Wagnert-Avraham, Dean Nachman, Jacob Megreli, Gil Shimon, Daniel Rimbrot, Ben Simon, Asaf Berman and 11 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Gal Yaniv *Institute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Arik Eisenkraft *Institute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel. aizenkra@gmail.com.
Lilach GavishInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Linn Wagnert-AvrahamInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Dean NachmanInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Jacob MegreliInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Gil ShimonInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Daniel RimbrotInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Ben SimonInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Asaf BermanInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Matan CohenInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
David KushnirCenter for Innovative Surgery, Hadassah Medical Center, Jerusalem, Israel.
Ruth ShaylorDivision of Anesthesiology and Intensive Care, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Baruch BatzofinThe Department of Anesthesiology, Hadassah Medical Center, Jerusalem, Israel.
Shimon FirmanThe Department of Anesthesiology, Hadassah Medical Center, Jerusalem, Israel.
Amir ShlaiferIsrael Defense Forces Medical Corps, Jerusalem, Israel.
Michael HartalThe Myers-JDC-Brookdale Institute, Jerusalem, Israel.
Yuval HeledIsrael Defense Forces Medical Corps, Jerusalem, Israel.
Elon GlassbergIsrael Defense Forces Medical Corps, Jerusalem, Israel.
Yitshak KreissSheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
S David GertzInstitute for Research in Military Medicine (IRMM), Faculty of Medicine, The Hebrew University of Jerusalem and the Israel Defense Forces Medical Corps, POB 12272, 91120, Jerusalem, Israel.
Hebrew University of Jerusalem · ILIsrael Defense Forces Medical Corps · ILHadassah Medical Center · ILSheba Medical Center · ILMyers-JDC-Brookdale Institute · ILTel Aviv Sourasky Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remote ischemic preconditioning (RIPC) involves deliberate, brief interruptions of blood flow to increase the tolerance of distant critical organs to ischemia. This study tests the effects of limb RIPC in a porcine model of controlled hemorrhage without replacement therapy simulating an extreme field situation of delayed evacuation to definitive care. Twenty-eight pigs (47 ± 6 kg) were assigned to: (1) control, no procedure (n = 7); (2) HS = hemorrhagic shock (n = 13); and (3) RIPC + HS = remote ischemic preconditioning followed by hemorrhage (n = 8). The animals were observed for 7 h after bleeding without fluid replacement. Survival rate between animals of the RIPC + HS group and those of the HS group were similar (HS, 6 of 13[46%]-vs-RIPC + HS, 4 of 8[50%], p = 0.86 by Chi-square). Animals of the RIPC + HS group had faster recovery of mean arterial pressure and developed higher heart rates without complications. They also had less decrease in pH and bicarbonate, and the increase in lactate began later. Global oxygen delivery was higher, and tissue oxygen extraction ratio lower, in RIPC + HS animals. These improvements after RIPC in hemodynamic and metabolic status provide essential substrates for improved cellular response after hemorrhage and reduction of the likelihood of potentially catastrophic consequences of the accompanying ischemia.

Indexed as

AnimalsArterial PressureDisease Models, AnimalFemaleHeart RateHemodynamicsIschemic PreconditioningMaleOxygenRecovery of FunctionShock, HemorrhagicSurvival AnalysisSwineOxygen

Identifiers

PMID34031524
PMCPMC8144617
OpenAlexW3165449905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.